StockNews.com initiated coverage on shares of Dynavax Technologies (NASDAQ:DVAX – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. DVAX has been the topic of several other research reports. HC Wainwright reduced their price target on shares of Dynavax Technologies from $28.00 to $27.00 and […]
Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]
Because of the increased demand for novel drug classes, the Oligonucleotide APIs Market Demand is predicted to rise at a high CAGR of 10.2% between 2022 and 2030. As a result, the global oligonucleotide API market is predicted to rise from US$ 2.46 billion in 2022 to US$ 5.36 billion by 2030.According to FMI’s analy.
Dynavax Technologies Co. (NASDAQ:DVAX – Get Rating) shares were down 4.8% on Monday after an insider sold shares in the company. The company traded as low as $10.63 and last traded at $10.73. Approximately 300,954 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 1,367,252 shares. The stock […]